Corporation will convene pharmaceutical research innovators at the 2014
PRO & eCOA Congress, the premier patient reported outcome (PRO)
and eClinical outcome assessment meeting, March 11-13 in Boston. PHT is
the leading provider of technologies used to collect patient-driven
eData for clinical research.
The PRO & eCOA Congress is an exclusive educational event for sponsors
focused on the science, technologies and regulatory requirements of PROs
and eCOAs. It is attended by professionals in clinical operations,
outsourcing, data management, eClinical technologies, regulatory
affairs, and health outcomes as well as industry thought leaders,
regulators and sites.
The clinical trials industry faces a very challenging operating
environment characterized by inefficiency, rising costs and smaller
market opportunities post launch. Keynote speaker Kenneth A. Getz's
presentation, "The New Norm for Global Clinical Trials: Patient-Centric
Engagement and Participation" will discuss the importance of
patient-centric and patient directed participation in clinical trials.
Compelling opportunities to leverage patient centricity in key areas
including protocol design and outcome measurement will be discussed.
This session will also highlight lessons learned from patient-centric
strategies and tactics that have been implemented during the past 18
Ken Getz is the director of sponsored research programs at the Center
for the Study of Drug Development, Tufts University School of Medicine
and the founder and chairman of the Center for Information and Study on
Clinical Research Participation (CISCRP), a non-profit organized to
educate and inform patients and the public about the role that clinical
research plays in advancing public health. He said, "I'm delighted to
join the PRO & eCOA Congress this year to discuss and learn about the
changin R&D paradigm and the critical need to engage patients as
partners in pre- and post-approval studies."
Additional confirmed speakers include representatives from Biogen Idec,
Celgene Corporation, Palatin Technologies, QualityMetric Inc. and PHT.
The complete agenda is available on-line.
Event sponsors include Bluebird Inc., Lionbridge Life Sciences,
Intel and Dell.
Sheila Rocchio, MBA, PHT Vice President of Marketing and Product
Management, said, "The PRO & eCOA Congress is where significant advances
in eClinical research begin, as pharma, key opinion leaders, scientists
and regulators share successes, opportunities and issues in adopting
eCOA technologies. Join us to get firsthand knowledge about regulatory
insights, lessons learned, emerging eCOA technology, and to network with
colleagues and industry leaders." Learn more about the PRO & eCOA
Congress in one minute: bit.ly/10390pi
Register for the 2014 PRO & eCOA Congress at bit.ly/16EYVSg.
Meet PHT at any US exhibited event by March 2014 and enter to win free
registration and a two night stay at the Taj Hotel, Boston: bit.ly/PHTEvents.
PHT invites all Congress alumni to join the PRO & eCOA Congress LinkedIn
Community to exchange information, ideas and experiences throughout
About PHT Corporation
PHT Corporation helps pharmaceutical companies and CROs conduct clinical
trial programs with greater confidence, ease and accuracy. Proven PHT
electronic clinical outcome assessment (eCOA) Systems collect
patient-driven eData via smartphones, tablets and the web. This data,
available via StudyWorks™
online reporting portal, provides sponsors and clinicians with a real
time window into how patients feel and function. PHT has helped trial
sponsors collect patient-driven eData in 660+ global trials resulting in
16+ regulatory approvals. PHT Clinical Science and Consulting offers the
scientific, regulatory, and technological expertise today's eCOA market
demands and patients deserve. Visit phtcorp.com
for more information on PHT. Follow PHT on LinkedIn,
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140204006472/en/
[ Back To NFVZone's Homepage ]